
Clinical Updates in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Tuesday, November 3, 2026 at 2:00 PM–3:00 PM EST Pricing: Free for Members and Non-Members
Please note that this session is not accredited for continuing pharmacy education credit.
Program Description
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare immune-mediated neuropathy that can result in significant long-term disability if diagnosis and treatment are delayed. In this AMCP Market Insights webinar, Dr. Ehtesham Khalid reviews recent advances in the understanding of CIDP, including emerging insights into disease pathophysiology, diagnostic challenges, current standards of care, and investigational therapies. Drawing on findings from AMCP's May 2026 Market Insights roundtable, the program highlights issues relevant to managed care professionals, including treatment timing, evolving mechanisms of action, and considerations for future coverage and access decisions.
Course summary
Speaker:
Ehtesham Khalid, MD, FRCPE, FCPS
Associate Professor of Neurology
Xavier-Ochsner College of Medicine and University of Queensland
Section Head, Neuromuscular Medicine
Ochsner Health
Moderator:
Charles Dragovish, BS Pharm
Consultant
AMCP Business Strategies
Price
By registering for this event, you agree not to use any form of artificial intelligence (AI) technology to record, transcribe, or reproduce educational sessions, presentations, or discussions in any format.
Click here for more information on AMCP membership or email memberservices@amcp.org.
Required Hardware/software
AMCP Learn utilizes the Zoom Webinars platform for live webinars. For a smoother experience joining the webinar, please install the Zoom desktop client or mobile app prior to the start time. If you experience technical issues joining the webinar, please email webinars@amcp.org.

Facebook
X
LinkedIn
Forward